Arkansas Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Buy |
7,185
+472
| +7% | +$31.4K | 0.07% | 64 |
|
|
2025
Q1 | $409K | Sell |
6,713
-210
| -3% | -$12.8K | 0.07% | 64 |
|
|
2024
Q4 | $455K | Sell |
6,923
-1,746
| -20% | -$115K | 0.07% | 63 |
|
|
2024
Q3 | $612K | Buy |
8,669
+3,454
| +66% | +$244K | 0.1% | 56 |
|
|
2024
Q2 | $346K | Buy |
+5,215
| New | +$346K | 0.06% | 61 |
|
|
2022
Q1 | – | Sell |
-3,081
| Closed | -$205K | – | 48 |
|
|
2021
Q4 | $205K | Buy |
+3,081
| New | +$205K | 0.04% | 47 |
|
|
2021
Q3 | – | Sell |
-3,270
| Closed | -$202K | – | 44 |
|
|
2021
Q2 | $202K | Buy |
+3,270
| New | +$202K | 0.05% | 45 |
|
|
2018
Q4 | – | Sell |
-3,588
| Closed | -$200K | – | 27 |
|
|
2018
Q3 | $200K | Buy |
+3,588
| New | +$200K | 0.08% | 24 |
|
|
2017
Q4 | – | Sell |
-3,882
| Closed | -$202K | – | 24 |
|
|
2017
Q3 | $202K | Hold |
3,882
| – | – | 0.09% | 22 |
|
|
2017
Q2 | $201K | Buy |
+3,882
| New | +$201K | 0.09% | 21 |
|
|
2016
Q1 | – | Sell |
-3,882
| Closed | -$209K | – | 22 |
|
|
2015
Q4 | $209K | Buy |
+3,882
| New | +$209K | 0.13% | 20 |
|
|
2015
Q3 | – | Sell |
-3,882
| Closed | -$226K | – | 21 |
|
|
2015
Q2 | $226K | Sell |
3,882
-390
| -9% | -$22.7K | 0.14% | 19 |
|
|
2015
Q1 | $246K | Buy |
4,272
+390
| +10% | +$22.5K | 0.15% | 20 |
|
|
2014
Q4 | $196K | Sell |
3,882
-1,215
| -24% | -$61.3K | 0.12% | 19 |
|
|
2014
Q3 | $238K | Hold |
5,097
| – | – | 0.16% | 19 |
|
|
2014
Q2 | $230K | Sell |
5,097
-402
| -7% | -$18.1K | 0.16% | 19 |
|
|
2014
Q1 | $232K | Sell |
5,499
-1,404
| -20% | -$59.2K | 0.17% | 19 |
|
|
2013
Q4 | $272K | Buy |
+6,903
| New | +$272K | 0.21% | 16 |
|